{"entity":{"id":"1969","kind":"year","name":"1969 in oncology","aka":["1969"],"tldr":"Everything OnCo dates to 1969: 10 entries, 5 landmarks, 3 approvals, 1 company founded and 1 journal founded. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.","summary":"10 dated entries in OnCo fall in 1969: 5 landmarks, 3 approvals, 1 company founded and 1 journal founded.\n\nOf those, 10 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.\n\nEverything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.","asOf":"2026-09-25","links":[],"tags":[],"related":["1968","1970"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Generated from every dated field in the corpus, not written by hand. The groups and the fields behind them are listed in src/lib/year-groups.ts; the reader is src/lib/years.ts."],"year":1969,"events":[{"group":"approval","date":"1969","precision":"year","title":"Cytarabine + anthracycline ('7+3') approved in US","note":"Cytarabine approved for acute leukaemia; 7+3 established 1973","from":"cytarabine-7-3","refs":[]},{"group":"approval","date":"1969","precision":"year","title":"Cytarabine approved in US","note":"Remission induction in acute non-lymphocytic leukaemia; ALL; blast-phase CML; intrathecal therapy of meningeal leukaemia","from":"cytarabine","refs":[]},{"group":"approval","date":"1969","precision":"year","title":"Procarbazine approved in US","note":"Stage III and IV Hodgkin disease in combination (MOPP)","from":"procarbazine","refs":[]},{"group":"company","date":"1969","precision":"year","title":"Venrock founded","note":"Palo Alto, CA","from":"venrock","refs":[]},{"group":"history","date":"1969","precision":"year","title":"Leksell treats the first acoustic neuroma with the Gamma Knife","note":"Vestibular schwannoma (acoustic neuroma)","from":"vestibular-schwannoma","refs":["gamma-knife","radiosurgery-srs"]},{"group":"history","date":"1969","precision":"year","title":"Melphalan and prednisone become the first standard for myeloma","note":"Newly diagnosed multiple myeloma, transplant-ineligible","from":"myeloma-transplant-ineligible","refs":["melphalan","prednisone"]},{"group":"history","date":"1969","precision":"year","title":"National Wilms Tumor Study (NWTS-1) begins","note":"Wilms tumour (nephroblastoma). Cooperative-group model that raised survival from ~30% to ~90% over five trials.","from":"wilms-tumor","refs":[]},{"group":"history","date":"1969","precision":"year","title":"Rosai and Dorfman define sinus histiocytosis with massive lymphadenopathy","note":"Rosai-Dorfman-Destombes disease","from":"rosai-dorfman-disease","refs":[]},{"group":"history","date":"1969","precision":"year","title":"Rosai and Dorfman describe sinus histiocytosis with massive lymphadenopathy","note":"Erdheim-Chester disease, Rosai-Dorfman disease and other histiocytic neoplasms. Destombes had reported cases in 1965.","from":"histiocytoses","refs":[]},{"group":"journal","date":"1969","precision":"year","title":"Journal of surgical oncology founded","note":"Wiley","from":"journal-of-surgical-oncology","refs":[]}]},"route":"/years/1969/","neighbours":{"year":[{"id":"1968","kind":"year","name":"1968 in oncology","route":"/years/1968/"},{"id":"1970","kind":"year","name":"1970 in oncology","route":"/years/1970/"}]}}